Edwards Henry D, Sabio Hernan, Shihabi Zak K
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA.
Ann Clin Lab Sci. 2009 Winter;39(1):32-7.
A rapid ( approximately 90 sec), fully automated method is described for quantifying hemoglobin S (HbS) by high performance liquid chromatography (HPLC) using the Bio-Rad Variant II Turbo analyzer. Although this instrument is designed to quantify only blood hemoglobin A1c (HbA1c), we show that it can also quantify accurately, without modification, HbS levels in sickle cell patients, provided the blood samples meet certain conditions. The samples should contain detectable hemoglobin F (HbF), but should not contain hemoglobin C (HbC). Under these conditions, blood HbS levels obtained by this method correlate well with those obtained by agarose electrophoresis (r(2) = 0.97, n = 81 patients). We also show that quantitation of blood HbF in sickle cell patients is more accurate by this method than by agarose electrophoresis when the HbF level is in the range from 0.2 to 10%.
本文描述了一种快速(约90秒)、全自动的方法,该方法使用Bio-Rad Variant II Turbo分析仪通过高效液相色谱法(HPLC)对血红蛋白S(HbS)进行定量分析。尽管该仪器设计用于仅定量血液糖化血红蛋白A1c(HbA1c),但我们表明,只要血样满足一定条件,它也能在不做修改的情况下准确地定量镰状细胞病患者的HbS水平。样本应含有可检测到的血红蛋白F(HbF),但不应含有血红蛋白C(HbC)。在这些条件下,通过该方法获得的血液HbS水平与通过琼脂糖电泳获得的水平具有良好的相关性(r² = 0.97,n = 81例患者)。我们还表明,当HbF水平在0.2%至10%范围内时,通过该方法对镰状细胞病患者血液HbF的定量比通过琼脂糖电泳更准确。